ATM, ATR and DNA-PKcs expressions correlate to adverse clinical outcomes in epithelial ovarian cancers

por Abdel-Fatah, Tarek M.A., Arora, Arvind, Moseley, Paul, Coveney, Clare, Perry, Christina, Johnson, Kerstie, Kent, Christopher, Ball, Graham, Chan, Stephen, Madhusudan, Srinivasan
Publicado 2014

The localization of pre mRNA splicing factor PRPF38B is a novel prognostic biomarker that may predict survival benefit of trastuzumab in patients with breast cancer overexpressing...

por Abdel-Fatah, Tarek M.A, Rees, Robert C, Pockley, A. Graham, Moseley, Paul, Ball, Graham R, Chan, Stephen Y.T, Ellis, Ian O, Miles, Amanda K
Publicado 2017

DNA repair prognostic index modelling reveals an essential role for base excision repair in influencing clinical outcomes in ER negative and triple negative breast cancers

por Abdel-Fatah, Tarek M.A., Arora, Arvind, Moseley, Paul M., Perry, Christina, Rakha, Emad A., Green, Andrew R., Chan, Stephen Y.T., Ellis, Ian O., Madhusudan, Srinivasan
Publicado 2015

HER2/HER3 heterodimers and p21 expression are capable of predicting adjuvant trastuzumab response in HER2+ breast cancer

por Green, Andrew R., Barros, Fabrício F. T., Abdel-Fatah, Tarek M. A., Moseley, Paul, Nolan, Christopher C., Durham, Alice C., Rakha, Emad A., Chan, Stephen, Ellis, Ian O.
Publicado 2014

Dissecting DNA repair in adult high grade gliomas for patient stratification in the post-genomic era

por Perry, Christina, Agarwal, Devika, Abdel-Fatah, Tarek M.A., Lourdusamy, Anbarasu, Grundy, Richard, Auer, Dorothee T., Walker, David, Lakhani, Ravi, Scott, Ian S., Chan, Stephen, Ball, Graham, Madhusudan, Srinivasan
Publicado 2014

Is There a Role for Base Excision Repair in Estrogen/Estrogen Receptor-Driven Breast Cancers?

por Abdel-Fatah, Tarek M.A., Perry, Christina, Arora, Arvind, Thompson, Nicola, Doherty, Rachel, Moseley, Paul M., Green, Andrew R., Chan, Stephen Y.T., Ellis, Ian O., Madhusudan, Srinivasan
Publicado 2014

ERCC1 Is a Predictor of Anthracycline Resistance and Taxane Sensitivity in Early Stage or Locally Advanced Breast Cancers

por Abdel-Fatah, Tarek M. A., Ali, Reem, Sadiq, Maaz, Moseley, Paul M., Mesquita, Katia A., Ball, Graham, Green, Andrew R., Rakha, Emad A., Chan, Stephen Y. T., Madhusudan, Srinivasan
Publicado 2019

Clinicopathological Significance of ATM-Chk2 Expression in Sporadic Breast Cancers: a Comprehensive Analysis in Large Cohorts()

por Abdel-Fatah, Tarek M.A., Arora, Arvind, Alsubhi, Nouf, Agarwal, Devika, Moseley, Paul M., Perry, Christina, Doherty, Rachel, Chan, Stephen Y.T., Green, Andrew R., Rakha, Emad, Ball, Graham, Ellis, Ian O., Madhusudan, Srinivasan
Publicado 2014

Immune-Phenotyping and Transcriptomic Profiling of Peripheral Blood Mononuclear Cells From Patients With Breast Cancer: Identification of a 3 Gene Signature Which Predicts Relapse...

por Foulds, Gemma A., Vadakekolathu, Jayakumar, Abdel-Fatah, Tarek M. A., Nagarajan, Divya, Reeder, Stephen, Johnson, Catherine, Hood, Simon, Moseley, Paul M., Chan, Stephen Y. T., Pockley, A. Graham, Rutella, Sergio, McArdle, Stephanie E. B.
Publicado 2018

Association of Sperm-Associated Antigen 5 and Treatment Response in Patients With Estrogen Receptor–Positive Breast Cancer

por Abdel-Fatah, Tarek M. A., Ball, Graham R., Thangavelu, Pulari U., Reid, Lynne E., McCart Reed, Amy E., Saunus, Jodi M., Duijf, Pascal H. G., Simpson, Peter T., Lakhani, Sunil R., Pongor, Lorinc, Győrffy, Balázs, Moseley, Paul M., Green, Andrew R., Pockley, Alan G., Caldas, Carlos, Ellis, Ian O., Chan, Stephen Y. T.
Publicado 2020

SHON expression predicts response and relapse risk of breast cancer patients after anthracycline-based combination chemotherapy or tamoxifen treatment

por Abdel-Fatah, Tarek M. A., Broom, Reuben J., Lu, Jun, Moseley, Paul M., Huang, Baiqu, Li, Lili, Liu, Suling, Chen, Longxin, Ma, Runlin Z., Cao, Wenming, Wang, Xiaojia, Li, Yan, Perry, Jo K., Aleskandarany, Mohammed, Nolan, Christopher C., Rakha, Emad A., Lobie, Peter E., Chan, Stephen Y. T., Ellis, Ian O., Hwang, Le-Ann, Lane, David P., Green, Andrew R., Liu, Dong-Xu
Publicado 2019